Biorestorative Therapies
BRTX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Biorestorative Therapies(BRTX) predict that the Revenue is 23.17 K (-7.32%), Miss estimate;the EBIT is -3.386 M (+29.57%), Beat estimate;the EPS is -0.12 (+81.25%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B7.32%
0.00B100.00%
-0.00B107.32%
EBITExceed expectations
-0.00B29.57%
-0.00B22.13%
+0.00B7.44%
EPSExceed expectations
-0.1281.25%
-0.268.75%
+0.080012.50%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf